The partners will work together on the diagnosis and treatment of cancer and rare and infectious diseases.
Motherboard looks into the UK's 100,000 Genomes Project.
The Genomics England Clinical Interpretation Partnership (GeCIP) comprises about 2,000 researchers in 30 research topics connected to the 100,000 Genomes Project.
Researchers at the Manchester Centre for Genomic Medicine are using the platform to identify genetic alterations tied to cancer and developmental disorders and disabilities.
Genomics England has selected Congenica, Omicia, NantHealth, and WuXi Nextcode to provide clinical interpretation services for rare diseases and cancer
Helomics will provide its technology to the GENE Consortium, formed to support the UK's 100,000 Genomes Project.
OGT is one of five companies selected to receive a second grant from the UK's Genomics England project, which it will use to continue developing a variant interpretation solution.
Edward Hockings and Lewis Coyne raise concerns in the Guardian regarding the UK's 100,000 Genomes Project and participant privacy.
The company will use the grant to complete and launch a population-scale graph-based genome reference tool and suite of related software to assemble and analyze whole genome samples.
The funding is part of a Small Business Research Initiative competition to promote the development of new technologies to advance the diagnostic application of genomic screening.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.